Investor profile
Eli Lilly
- Portfolio companies
- 4
- Known capital represented
- $261M
Capital represented is the total size of rounds in this ledger, not the investor's individual check size.
Known activity
Portfolio rounds
Lead and participating investments
- ParticipatingThatch
Series C · Sep 15, 2026
$108M
- ParticipatingCaspian Therapeutics
Seed · Sep 9, 2026
$50M
- ParticipatingMoonwalk Biosciences
Series B · Sep 7, 2026
$70M
- ParticipatingCloverleaf Bio
Seed · Sep 7, 2026
$33M

